I am writing regarding the article about multiple sclerosis and stem cell treatments (“Immune system reboot,” Sept. 15). This is to inform folks suffering from MS that there is another approach to healing MS. This approach has research supporting its efficacy, it is noninvasive, less expensive and available locally.

Over the past two decades, extensive international medical research has demonstrated that hyperbaric oxygen therapy can play an important role in the treatment of MS. In many European countries, HBOT is now considered an integral part of an MS treatment program. By 1984, Dr. Richard Neubauer and others had studied the impact of HBOT on over 10,000 MS patients in 14 countries. Of these patients, 70% improved both brain, bladder and bowel function and their muscle spasticity declined. Twenty-five percent of the patients had measurable improvements.

Dr. Shai Efrati from the Sackler Faculty of Medicine and the Sagol School of Neuroscience at Tel Aviv University spearheaded the research that produced evidence that HBOT increased telomere length, decreased senescent cells (which suppress innate smooth muscle cell repair functions in atherosclerosis) and increased stem cell production by as much as eight times.

Generally speaking, the initial HBOT treatment program for MS is one month in duration. Evidence suggests that treatment is provided in a medical-grade hard-sided chamber under specific protocols with a doctor’s prescription and oversight.

George Glass

Durango